Her research interests include resiliency, psychoneuroimmunology, neuroplastic pain, placebo/ nocebo effect, and bioenergy therapies
noticeable effects often after first use Clinical Insights: Effects may be more noticeable on days of higher cognitive demand Tolerated well at low doses with minimal side effects Can be used acutely or in cycles for sustained performance May be synergistic when paired with other mitochondrial therapies Investigated for neurodegenerative support (e.g., Alzheimers, Parkinsons) Methylene Blue helps supercharge your mitochondria and enhance brain function
The GIP receptor is not primarily expressed in the liver, so the glucagon-specific hepatic benefits are absent
Combining them would not shorten either schedule
Decades of use data do not exist for this compound in humans
Study 3: Heffernan 2000, oral administration Citation: Heffernan M., Jiang W.J., Thorburn A.W., Ng F.M